Enzymatic status of blood lymphocytes in young children with Epstein-Barr virus infection

L M Kurtasova1, A E Golovanova, A A Savchenko

  • 1V. F. Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia. aids@ktk.ru

Insights

Enzyme activity in lymphocytes of young children with Epstein-Barr virus infection was tracked. Changes in NAD(PH)-dependent dehydrogenases correlated with disease stages and persisted even after recovery.

Area of Science:

  • Biochemistry
  • Immunology
  • Pediatrics

Background:

  • Epstein-Barr virus (EBV) infection can cause significant health issues in young children.
  • NAD(PH)-dependent dehydrogenases play crucial roles in cellular metabolism and immune cell function.
  • Understanding enzymatic changes in lymphocytes during EBV infection is important for assessing disease dynamics.

Purpose of the Study:

  • To investigate the activity of NAD(PH)-dependent dehydrogenases in peripheral blood lymphocytes of children aged 1-3 years with Epstein-Barr virus infection.
  • To analyze the relationship between enzyme activity changes and the different stages of the disease.
  • To determine if enzymatic status normalization occurs during the convalescence period.

Main Methods:

  • Peripheral blood lymphocytes were isolated from children diagnosed with Epstein-Barr virus.
  • Activity assays were performed for key NAD(PH)-dependent dehydrogenases.
  • Enzyme activities were monitored dynamically throughout the course of the disease and convalescence.

Main Results:

  • A significant relationship was observed between the activity levels of NAD(PH)-dependent dehydrogenases and the progression of Epstein-Barr virus disease.
  • Specific patterns of enzyme activity changes were identified correlating with acute infection and recovery phases.
  • Enzymatic disorders in blood lymphocytes were found to persist into the convalescence period, indicating prolonged cellular impact.

Conclusions:

  • NAD(PH)-dependent dehydrogenase activity in lymphocytes is altered during Epstein-Barr virus infection in young children.
  • These enzymatic changes are linked to disease dynamics and do not fully resolve upon clinical recovery.
  • Further research into lymphocyte enzymatic status may provide insights into long-term EBV effects and potential therapeutic targets.

Related Concept Videos